Could oritavancin be a promising alternative treatment for staphylococcal bone and joint infections? Insights from the determination of oritavancin minimum inhibitory concentrations in a collection of clinical isolates from the French National reference centre for staphylococci

European Journal of Clinical Microbiology & Infectious Diseases 2026

View at publisher
Authors: M. Berrada, Camille Kolenda, Anne Tristan, Frédéric Laurent, Céline Dupieux
DOI: 10.1007/s10096-025-05383-3
Cited by: 0
References: 19

Fields of Study & Subjects

Orthopedic Infections and Treatments Antimicrobial Resistance in Staphylococcus Antimicrobial Peptides and Activities

Publication details

Journal / source
European Journal of Clinical Microbiology & Infectious Diseases
Volume
45
Issue
5
Pages
1477–1481
Publication date
6 January 2026
Language
EN